quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:03:51·42d
SECFiling
OptimizeRx Corporation logo

SEC Form 10-K filed by OptimizeRx Corporation

OPRX· OptimizeRx Corporation
Real Estate
Original source

Companies

  • OPRX
    OptimizeRx Corporation
    Real Estate

Recent analyst ratings

  • Jan 8UpdateRBC Capital Mkts$6.00
  • Dec 20UpdateStephens$5.50
  • Jul 25UpdateB. Riley Securities$18.50
  • Apr 4UpdateJMP Securities$15.00
  • Jan 3UpdateBarclays$15.00
  • Feb 2UpdateB. Riley Securities$30.00

Related

  • INSIDER1d
    SEC Form 3 filed by new insider Presti Mariyamma Varghese
  • PR7d
    Myomo Appoints William J Febbo to its Board of Directors
  • PR15d
    OptimizeRx Appoints Mary Varghese Presti to Board of Directors
  • SEC24d
    OptimizeRx Corporation filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by OptimizeRx Corporation
  • PR49d
    UPDATE – OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
  • SEC49d
    OptimizeRx Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits
  • PR49d
    OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022